Viewing Study NCT01704495


Ignite Creation Date: 2025-12-24 @ 1:41 PM
Ignite Modification Date: 2025-12-29 @ 9:34 PM
Study NCT ID: NCT01704495
Status: COMPLETED
Last Update Posted: 2016-03-01
First Post: 2012-10-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.
Sponsor: AstraZeneca
Organization: